A detailed history of Canopy Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Canopy Partners, LLC holds 7,652 shares of EW stock, worth $572,446. This represents 0.22% of its overall portfolio holdings.

Number of Shares
7,652
Previous 9,158 16.44%
Holding current value
$572,446
Previous $846 Million 40.31%
% of portfolio
0.22%
Previous 0.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$59.7 - $93.78 $89,908 - $141,232
-1,506 Reduced 16.44%
7,652 $505 Million
Q2 2024

Aug 09, 2024

SELL
$84.3 - $94.31 $1,517 - $1,697
-18 Reduced 0.2%
9,158 $846 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $11,461 - $15,098
158 Added 1.75%
9,176 $877 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $556,500 - $701,239
9,018 New
9,018 $688 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Canopy Partners, LLC Portfolio

Follow Canopy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canopy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canopy Partners, LLC with notifications on news.